Zoetis (MEX:ZTS) Total Equity: MXN58,300 Mil (As of Mar. 2026)


MEX:ZTS Zoetis Inc MEX:ZTS
71 GF Score
Price MXN1,315.20
GF Value MXN3,410.33
Valuation Significantly Undervalued
View Full Analysis

What is Zoetis Total Equity?

Zoetis MEX:ZTS -1.70% 71 Total Equity is MXN58,300 Mil as of Mar. 2026. GuruFocus rates MEX:ZTS with a GF Score™ of 71/100 and a GF Value™ of MXN3,410.33 (Significantly Undervalued).

Zoetis's total equity for the quarter that ended in Mar. 2026 was MXN58,300 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Zoetis Total Equity Historical Data

* Premium members only.

The historical data trend for Zoetis's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zoetis Total Equity Chart

Zoetis Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 93,215.62 85,840.89 84,718.47 99,481.69 59,976.99

Zoetis Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 95,232.92 93,712.93 99,021.99 59,976.99 58,299.72
MEX:ZTS
71GF Score
Zoetis Inc MEX:ZTS
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zoetis Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Zoetis's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=278494.162-218517.175
=59,977

Zoetis's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=273267.536-214967.817
=58,300

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of MXN58,300 Mil mean?
Zoetis (MEX:ZTS) has a Total Equity of MXN58,300 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Zoetis and its competitors.
Is Zoetis' Total Equity too high?
Zoetis' current Total Equity is MXN58,300 Mil. Overall, Zoetis has a GF Score™ of 71/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zoetis' Total Equity compare to UTHR and VTRS?
Zoetis' Total Equity of MXN58,300 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Drug Manufacturers company?
A good Total Equity depends on the Drug Manufacturers industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Zoetis and its competitors. Zoetis's current Total Equity is MXN58,300 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zoetis stock overvalued right now?
Based on GuruFocus' analysis, Zoetis (MEX:ZTS) is currently considered Significantly Undervalued. The stock's GF Value™ is MXN3,410.33, compared to a current price of MXN1,315.20 — trading 61.4% below its estimated fair value. The current Total Equity is MXN58,300 Mil. Zoetis' overall GF Score™ is 71/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Zoetis (MEX:ZTS), the current Total Equity is MXN58,300 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zoetis (MEX:ZTS) Overvalued in 2026?

Based on GuruFocus' analysis, Zoetis stock appears to be undervalued. The current stock price of MXN1,315.20 is trading 61.4% below its estimated GF Value™ of MXN3,410.33. GuruFocus considers Zoetis to be Significantly Undervalued.

Key valuation signals for MEX:ZTS:

  • Total Equity: MXN58,300 Mil
  • GF Value™: MXN3,410.33 vs. price of MXN1,315.20 (61.4% below fair value)
  • GF Score™: 71/100

No single metric tells the full story. See the MEX:ZTS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zoetis Business Description

Address 10 Sylvan Way, Parsippany, NJ, USA, 07054
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
71GF Score

Get the complete analysis for MEX:ZTS

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1,315.20
Price
MXN3,410.33
GF Value